The total pharmaceutical market in Finland demonstrated moderate growth with certain fluctuations over the past decade. As of 2023, the market stood at 19 units of generics in value, reflecting no growth compared to the previous year. In the last two years, the market saw a 5% decline in 2022 followed by stabilization in 2023. The average annual growth rate (CAGR) over the past five years has been 2.25%, indicating a modest upward trend. Future forecasts predict a stable market with the value remaining around 20 units of generics by 2028, representing an average annual growth rate of 1.03% and a total growth rate of 5.26% over five years.
Future trends to watch for include:
- Potential impacts of healthcare policy changes and reimbursement schemes.
- Innovations and advancements in pharmaceutical technologies and products.
- Trends in generic drug consumption and market penetration.
- Economic factors including pricing pressures and regulatory considerations.
